Jonathan Slonin, Chief Medical Officer at Pacira BioSciences ($PCRX), made one open market sale of company shares in the last year, totaling $95,400. His most recent transaction occurred on November 17, 2025. Among 11,700 insiders with sales, his activity ranks 9,656th by value, well below the average of 8.6 million dollars per person across about 6.4 trades. Slonin recorded no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 17, 2026 | Pacira BioSciences, Inc. | $PCRX | SLONIN JONATHAN | Chief Medical Officer | S | Common Stock | 3261 | $22.82 | 223,640.1750 | 45,729,000 | 1.44% | 0.01% |
| Feb. 11, 2026 | Pacira BioSciences, Inc. | $PCRX | SLONIN JONATHAN | Chief Medical Officer | A | Common Stock | 54546 | $0.00 | 226,901.1750 | 45,729,000 | 31.65% | 0.12% |
| Jan. 30, 2026 | Pacira BioSciences, Inc. | $PCRX | SLONIN JONATHAN | Chief Medical Officer | F | Common Stock | 6168 | $20.54 | 172,355.1750 | 45,729,000 | 3.46% | 0.01% |
| Jan. 2, 2026 | Pacira BioSciences, Inc. | $PCRX | SLONIN JONATHAN | Chief Medical Officer | F | Common Stock | 381 | $24.46 | 178,523.1750 | 45,729,000 | 0.21% | 0.00% |
| Nov. 17, 2025 | Pacira BioSciences, Inc. | $PCRX | SLONIN JONATHAN | Chief Medical Officer | S | Common Stock | 3960 | $24.09 | 178,367.0090 | 45,729,000 | 2.17% | 0.01% |
| Aug. 1, 2025 | Pacira BioSciences, Inc. | $PCRX | SLONIN JONATHAN | Chief Medical Officer | F | Common Stock | 315 | $22.07 | 182,327.0090 | 46,245,000 | 0.17% | 0.00% |
| June 3, 2025 | Pacira BioSciences, Inc. | $PCRX | SLONIN JONATHAN | Chief Medical Officer | F | Common Stock | 5084 | $26.40 | 181,959.5110 | 46,245,000 | 2.72% | 0.01% |
| Feb. 1, 2025 | Pacira BioSciences, Inc. | $PCRX | SLONIN JONATHAN | Chief Medical Officer | A | Common Stock | 93600 | $0.00 | 187,043.5110 | 46,245,000 | 100.17% | 0.20% |
| Jan. 6, 2025 | Pacira BioSciences, Inc. | $PCRX | SLONIN JONATHAN | Chief Medical Officer | S | Common Stock | 879 | $18.40 | 93,443.5110 | 46,245,000 | 0.93% | 0.00% |
| Jan. 2, 2025 | Pacira BioSciences, Inc. | $PCRX | SLONIN JONATHAN | Chief Medical Officer | F | Common Stock | 371 | $18.33 | 94,322.5110 | 46,245,000 | 0.39% | 0.00% |
| Aug. 2, 2024 | Pacira BioSciences, Inc. | $PCRX | SLONIN JONATHAN | Chief Medical Officer | S | Common Stock | 945 | $20.05 | 94,306.7460 | 51,979,000 | 0.99% | 0.00% |
| Aug. 1, 2024 | Pacira BioSciences, Inc. | $PCRX | SLONIN JONATHAN | Chief Medical Officer | F | Common Stock | 305 | $20.75 | 95,251.7460 | 51,979,000 | 0.32% | 0.00% |
| July 2, 2024 | Pacira BioSciences, Inc. | $PCRX | SLONIN JONATHAN | Chief Medical Officer | S | Common Stock | 2836 | $28.25 | 95,556.7460 | 51,979,000 | 2.88% | 0.01% |
| July 1, 2024 | Pacira BioSciences, Inc. | $PCRX | SLONIN JONATHAN | Chief Medical Officer | F | Common Stock | 914 | $28.46 | 98,392.7460 | 51,979,000 | 0.92% | 0.00% |
| June 28, 2024 | Pacira BioSciences, Inc. | $PCRX | SLONIN JONATHAN | Chief Medical Officer | A | Common Stock | 437 | $24.32 | 99,306.7460 | 51,979,000 | 0.44% | 0.00% |
| June 12, 2024 | Pacira BioSciences, Inc. | $PCRX | SLONIN JONATHAN | Chief Medical Officer | A | Common Stock | 54300 | $0.00 | 98,869.4750 | 51,979,000 | 121.83% | 0.10% |
| June 11, 2024 | Pacira BioSciences, Inc. | $PCRX | SLONIN JONATHAN | Chief Medical Officer | S | Common Stock | 5012 | $28.57 | 44,569.4750 | 51,979,000 | 10.11% | 0.01% |
| June 3, 2024 | Pacira BioSciences, Inc. | $PCRX | SLONIN JONATHAN | Chief Medical Officer | F | Common Stock | 1615 | $30.89 | 49,581.4750 | 51,979,000 | 3.15% | 0.00% |
| Jan. 3, 2024 | Pacira BioSciences, Inc. | $PCRX | SLONIN JONATHAN | Chief Medical Officer | A | Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 51,979,000 | 9999.99% | 0.02% |
| Jan. 2, 2024 | Pacira BioSciences, Inc. | $PCRX | SLONIN JONATHAN | Chief Medical Officer | A | Common Stock | 5000 | $0.00 | 51,196.4750 | 51,979,000 | 10.82% | 0.01% |
| June 7, 2023 | Pacira BioSciences, Inc. | $PCRX | SLONIN JONATHAN | Chief Clinical Officer | S | Common Stock | 490 | $37.87 | 36,323.0000 | 46,538,000 | 1.33% | 0.00% |
| June 6, 2023 | Pacira BioSciences, Inc. | $PCRX | SLONIN JONATHAN | Chief Clinical Officer | S | Common Stock | 471 | $38.99 | 36,813.0000 | 46,538,000 | 1.26% | 0.00% |